Global Cord Blood Profit Margin

As of the most recent data (July 2022), CO shows a profit margin of 38.59%. That compares with 42.9% in the prior-year period — down 10.0% year over year. That is above the Healthcare sector average of 21.34%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CO's profit margin is now 38.59% (was 42.9%) — a 10.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Global Cord Blood is outperforming or lagging.

The Healthcare sector average profit margin is about 21.34%. Global Cord Blood is at 38.59%, which is higher that average. That is roughly 80.9% above the sector mean. Use the comparison chart on this page to see how CO stacks up against individual peers as well.

That compares with 42.9% in the prior-year period — down 10.0% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Global Cord Blood with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Global Cord Blood's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 38.59%) with ownership activity and broader fundamentals.